HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Immunological study on Alzheimer's disease using anti-beta-protein monoclonal antibodies].

Abstract
Monoclonal antibodies (TB1 & TB2), which were obtained by immunization of 24 amino acids in BALB/c mice, bound specifically to the amyloid senile plaque and amyloid-angiopathic lesions of brain tissues of patients with Alzheimer's disease (AD) or with senile dementia of Alzheimer type (SDAT), and strongly reacted with the 1st part (Asp-Ala-Glu-Phe-Arg-His-Asp) of beta-protein. Western blotting and two-dimensional immunoelectrophoresis of cerebrospinal fluid (CSF) and serum revealed bands of 125 and 20 kilodaltons. The positive frequency of 125 and 20 KD bands detected by two-dimensional immunoelectrophoresis was higher in the serum of AD and SDAT patients (12 cases) than in that of normal control patients. ELISA employing various anti-amyloid precursor protein (APP) antibodies was performed using the extract of the human neuroblastoma cell line (NB39) which produces APP. In the near future, we hope to measure APP in CSF and sera from patients with Alzheimer's disease.
AuthorsM Ota, K Imai, N Saito, F Ito, M Tsujisaki, T Sugiyama, Y Hinoda, A Yachi, M Kasai, M Kawaharada
JournalNihon Ronen Igakkai zasshi. Japanese journal of geriatrics (Nihon Ronen Igakkai Zasshi) Vol. 30 Issue 1 Pg. 23-9 (Jan 1993) ISSN: 0300-9173 [Print] Japan
PMID8474224 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amyloid beta-Peptides
  • Antibodies, Monoclonal
Topics
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease (diagnosis, metabolism)
  • Amino Acid Sequence
  • Amyloid beta-Peptides (analysis, immunology)
  • Antibodies, Monoclonal
  • Female
  • Humans
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Radioimmunoassay

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: